High-precision translation engineering begins with clean RNA. At GCEngine, where tRNA concentration, modification, and ncAA incorporation must be tightly regulated, genomic DNA contamination poses a critical risk—interfering with quantitative accuracy, enzymatic reactions, and orthogonal system performance. Our genomic DNA contamination removal service provides a specialized purification solution designed for engineered tRNA and aaRS expression workflows.
Even trace gDNA can inflate A260 readings, seed false signals in qPCR, and interfere with enzyme workflows. Because DNA and RNA co-purify, gDNA must be removed and verified with methods that are selective for dsDNA and controlled for reverse-transcription artifacts.
At the GCEngine platform, gDNA removal integrates RNase-free DNase, small-RNA–retentive cleanup, and method-traceable verification. Results are reported against fit-for-purpose limits and can be bundled with Purity or Integrity assessments.
Scope.This module is assay-agnostic. It does not guarantee translational performance; it documents gDNA status for handoff to Purity / Integrity / Functional modules.
The GCEngine genomic DNA contamination removal service integrates enzymatic degradation, adsorption-based purification, and analytical verification into a seamless, high-recovery workflow. Each project is customized to the molecular type (tRNA, mRNA, or total RNA) and sample origin (in vitro transcription, microbial expression, or mammalian systems).
We focus on preserving RNA integrity and functional modifications while reducing DNA residues to levels below the detection limit of standard fluorescence and qPCR assays.
Enzymatic DNA Degradation
The GCEngine platform workflow begins with a DNA-specific enzymatic digestion step using DNase I or recombinant Turbo DNase under controlled ionic and temperature conditions. Reaction parameters are carefully optimized to degrade chromosomal and plasmid DNA while preserving full-length tRNA structure and chemical modifications. Each batch is immediately stabilized post-digestion to prevent overexposure or inadvertent RNA cleavage, ensuring maximum RNA recovery.
Adsorptive and Column-Based Purification
Following enzymatic digestion, samples undergo dual-stage purification using silica membrane or magnetic-bead columns designed for small RNA retention. This step removes residual nucleotides, metal cofactors, and enzyme proteins while selectively retaining size-specific RNA ( <200nt). The process produces high-purity RNA suitable for concentration measurement, aminoacylation assays, or downstream orthogonal translation studies within GCEngine.
Chemical and Spectral Quality Verification
After purification, we perform Qubit™ dsDNA assays to detect DNA at sub-nanogram levels, ensuring that residual genomic material is below analytical detection limits. UV–Vis spectral ratios (A260/280 ≈ 1.9–2.1 and A260/230 ≥ 2.0) are reported as supporting evidence only, since absorbance-based methods cannot independently confirm the absence of DNA.
Optional qPCR and Amplification Control Test
For applications requiring higher assurance, we perform locus-specific qPCR or endpoint PCR targeting genomic or vector-derived sequences. Each assay includes +RT, no-RT, and no-template controls. Successful gDNA clearance is confirmed when the no-RT control shows no amplification or meets a predefined threshold (e.g., ΔCt ≥ 12 relative to +RT). For loci prone to RNA-derived interference, we employ genome-specific primers or DNase-resistant spike-in references to avoid false positives.
Genomic DNA contamination may be invisible, but its impact on translational accuracy is significant. The GCEngine platform helps ensure that your RNA preparations—especially orthogonal tRNAs used for ncAA incorporation—are minimally impacted by genomic DNA interference, supporting accurate quantification, functional reproducibility, and high-fidelity translation. Contact us today to integrate genomic DNA contamination removal into your GCEngine workflow and maintain uncompromised molecular precision across all ncAA-related applications.
A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.